Oxford Pharmascience (OXP): 2014 Price Channel Targets 12p

As far as shares of Oxford Pharmascience are concerned over the near-term it can be seen on the daily chart how we have a classic technical turnaround in place. The highlight for short term traders, especially since the start of the year is the way that they have been treated to an unfilled gap through the 50 day moving average in January, an event which is typically seen only in the strongest of recovery situations.

Oxford Pharmascience

When you add in the way that last month the longs were treated to a golden cross buy signal between the 50 day and 200 day moving averages, then may be said that it is hardly surprising the shares have subsequently delivered a near vertical push to the upside.

The current position is that while some may be concerned that the stock has travelled too far and too fast, we should still assume that there is considerable positive momentum still left in this situation. Such an assumption is backed by the way it is possible to draw a rising trend channel from October 2013, a feature which should be able to guide the stock higher still over the next 1 to 2 months.

The favoured scenario is that while the floor of the latest the shaped Bull flag at 7.25p remains in place as support on an end of day close basis we are justified in targeting the price channel top. This is currently stretching as high as 12p.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    DirectorsTalk

    More articles like this

    AI impact on biopharma business models

    The culture of collaboration in the Pacific Northwest, the impact of AI on biopharma, and the shape of new business models driven by AI were all topics at a panel discussion Wednesday in Seattle at the

    Union Jack Oil

    Union Jack appoints Craig Howie as NED

    Union Jack Oil plc has appointed Craig Howie as an independent non-executive director, with effect from 22 April 2024. He will be chairman of the audit committee and member of the remuneration committee when current NED

    Ilika plc

    The future of Smart Contact Lenses and Ilika’s role

    Introduction Originally developed to replace glasses for helping people see better, contact lenses are now moving into a ‘smart’ era. Not only could smart contact lenses revolutionise healthcare for approx. 253 million people worldwide who have

    Path Investments

    DG Innovate’s Sustainable Mobility and Energy Storage innovations

    DG Innovate, a leader in sustainable mobility and energy storage solutions, has released its Annual Report for 2023, highlighting the development of high-efficiency electric motors and cost-effective sodium-ion batteries. These innovations promise greater energy density at

    A major UK Manufacturing report reveals surprising statistics

    Manufacturing is having a far greater impact on the UK economy than first thought according to a major new report released by the country’s Manufacturing Technology Association. ‘The True Impact of UK Manufacturing’, which was unveiled

    Alien Metals granted 21-Year mining lease for Hancock Iron-Ore project

    The Western Australia Department of Mines, Industry Regulation and Safety has granted Aim-listed Alien Metals a mining lease for the Hancock iron-ore project. This represents a key milestone on the pathway towards development of the project and provides Alien with security of tenure for a

    Warpaint London

    Warpaint London plc reports Record Sales and Profits in 2023

    Warpaint London plc (LON:W7L), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands, has announced its audited results for the year ended 31 December 2023. Financial Highlights ·    Strong growth in sales,